BioCubaFarma

Cuba on the path to biosimilar drugs

Published on: January 29, 2026
09:21

Havana, Jan 29 (Prensa Latina) The Cuban biopharmaceutical industry has included in its 2025-2035 strategy the development of 19 biosimilar and generic products, primarily for oncology, autoimmunity, hematology, and diabetes mellitus.

Cuba with new drugs for thrombosis and hypertension

Published on: January 26, 2026
10:37

Havana, Jan 26 (Prensa Latina) A group of 408 research projects, including new products for human health such as one developed for the prevention of deep vein thrombosis, is among the results of the BioCubaFarma business group in 2025, it was revealed.

International organizations highlight Cuba’s anti-Covid-19 vaccines

Published on: September 17, 2021
07:11

Havana, Sep 17 (Prensa Latina) International organizations and experts highlighted the significance of Cuba's anti-Covid-19 vaccines for the region and the world, amid a complex health crisis caused by the Covid-19 pandemic.

BioCubaFarma denies information of refusal to certify Cuban vaccines

Published on: September 2, 2021
07:07

Havana, Sep 2 (Prensa Latina) BioCubaFarma Business Group on Wednesday denied CNN´s information about alleged refusal from the World Health Organization (WHO) to certify Cuba's Covid-19 vaccines. The CNN aired on Wednesday that WHO refused authorization for the emergency use of Cuban vaccine candidate (Abdala), so it cannot be purchased through the Revolving Fund of the Pan American Health Organization (PAHO).

Cuba bets on medical sovereignty despite US blockade

Published on: June 22, 2021
06:53

Havana, Jun 22 (Prensa Latina) With more than 100 innovation projects, the Cuban Group of Biotechnological and Pharmaceutical Industries (BioCubaFarma) currently continues with the development of new medications, despite the United States blockade against the Caribbean nation.

NEWS